The Company reaffirms its previous IM8 revenue guidance of $180M to $200M for full year 2026, implying: $21M to $25M in monthly revenue for IM8 by the end of 2026; $250M to $300M in ARR for IM8 by the end of 2026; Adjusted EBITDA loss for full year 2026 is expected to be approximately $16M to $20M, in line with the adjusted EBITDA losses in full years 2025 and 2024, with a trajectory towards adjusted EBITDA profitability by Q4 of 2027.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRE:
- Prenetics Reshapes Board and Strategy to Accelerate Global IM8 Longevity Push
- Prenetics Sells Insighta Stake to Tencent for $70 Million, Sharpening Focus on IM8
- Prenetics completes $70M Insighta Sale to Tencent
- Is PRE a Buy, Before Earnings?
- Prenetics announces Formula 1’s Ollie Bearman as newest Global Ambassador